![Anup Arora](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Prior to joining Easton Capital in 2006, Mr. Arora had five years of consulting and operating experience in pharmaceuticals and biotechnology.
Most recently, he worked in global marketing at Pfizer, where he set marketing strategy and prioritized clinical investments within the arthritis and pain area.
Before joining Pfizer, Mr. Arora was a consultant with Strategic Decision Group, where he advised life sciences companies in the US and Europe on strategic and investment decisions in R&D, marketing, and business development.
Previously, he worked for two years in biomedical research at Stanford University.
Mr. Arora holds an MBA with High Distinction (Baker Scholar) from Harvard Business School and dual bachelor’s degrees in Biology and Psychology from Stanford University.
| Sociétés | Poste | Début |
|---|---|---|
K2 HealthVentures Group LLC
 K2 HealthVentures Group LLC Investment ManagersFinance K2 HealthVentures (K2HV) seeks investment opportunities in both public and private companies located in the United States. The firm targets businesses operating in life sciences and healthcare industry. It provides debt and equity financing for early to late stage capital requirements with an investment size ranging between USD 10 million and USD 100 million. | Fondateur | 01/01/2018 |
| Sociétés | Poste | Fin |
|---|---|---|
| GENETIX BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | - |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Strategic Decision Group, Inc.
 Strategic Decision Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategic management consulting services | Corporate Officer/Principal | - |
Easton Capital Investment Group
 Easton Capital Investment Group Investment ManagersFinance Easton invests in all segments of the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. The firm is stage-agnostic and considers opportunities from early-stage venture capital to later-stage growth capital with investment size ranging from $0.05 - $10 million. They are generally not a seed-stage investor. | Analyste en capital-investissement | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 6 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
bluebird bio, Inc.
 bluebird bio, Inc. BiotechnologyHealth Technology Develops genetic therapies based on blood stem cells | Health Technology |
Strategic Decision Group, Inc.
Strategic Decision Group, Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategic management consulting services | Commercial Services |
Easton Capital Investment Group
Easton Capital Investment Group Investment ManagersFinance Easton invests in all segments of the healthcare industry, including biopharmaceuticals, drug delivery, medical devices and healthcare services. The firm is stage-agnostic and considers opportunities from early-stage venture capital to later-stage growth capital with investment size ranging from $0.05 - $10 million. They are generally not a seed-stage investor. | Finance |
K2 HealthVentures Group LLC
K2 HealthVentures Group LLC Investment ManagersFinance K2 HealthVentures (K2HV) seeks investment opportunities in both public and private companies located in the United States. The firm targets businesses operating in life sciences and healthcare industry. It provides debt and equity financing for early to late stage capital requirements with an investment size ranging between USD 10 million and USD 100 million. | Finance |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
